SRPT
SAREPTA THERAPEUTICS INCData as of 2026 Q2 (06-30) · 13F snapshot
Summary
SAREPTA THERAPEUTICS INC (SRPT) is held as common stock by 4 tracked hedge-fund managers, with a combined reported value of ~$53.51M; the largest are Izzy Englander, Renaissance Technologies, Steven Cohen. 1 tracked manager also disclosed PUT or CALL positions, reported separately below. This quarter: 1 new, 1 added, 2 trimmed, 2 closed. 20 public STOCK Act / OGE trade disclosures are on record. Data as of 2026 Q2, from public SEC 13F filings, delayed up to ~45 days.
Attention · MediumThis quarter · Cooling
Common-stock holders41 also report options
Congress trades20
Price$18.80vs quarter-end+4.62%
Sectors0
This quarter's moves
Top holderNew1
Added1
Trimmed / sold4
Izzy EnglanderCommon-stock positions
PUT and CALL disclosures are excluded from these holder counts and values.
| Investor | Value | % of portfolio | Action |
|---|
PUT / CALL disclosures
Reported separately: 13F option values are not common-stock ownership and do not reveal the full strategy or economic exposure.
Value $23.73M— of portfolio1,320,4002026 Q2
Value $4.02M— of portfolio223,7002026 Q2
| Investor | Value | % of portfolio | Action |
|---|---|---|---|
| Ken GriffinCALL | $23.73M | — | — |
| Ken GriffinPUT | $4.02M | — | — |
Public SEC 13F filings may appear up to 45 days after quarter-end; STOCK Act / OGE trade filings are generally due within 45 days but may be late. Partial data only — research, not investment advice.